ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 374 filers reported holding ROYALTY PHARMA PLC in Q2 2024. The put-call ratio across all filers is 0.45 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,489,593 | -13.8% | 56,488 | -0.7% | 0.06% | -16.7% |
| Q1 2024 | $1,728,118 | -6.3% | 56,902 | -13.3% | 0.07% | -14.3% |
| Q4 2023 | $1,844,586 | -11.7% | 65,667 | -14.7% | 0.08% | -19.2% |
| Q3 2023 | $2,089,326 | -78.8% | 76,983 | -76.0% | 0.10% | -77.8% |
| Q2 2023 | $9,841,752 | -14.5% | 320,160 | +0.2% | 0.47% | -19.0% |
| Q1 2023 | $11,512,931 | +24.9% | 319,537 | +37.0% | 0.58% | +17.5% |
| Q4 2022 | $9,219,977 | – | 233,299 | – | 0.49% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIGULER GUFF ADVISERS, LLC | 6,761,970 | $338,436,000 | 92.73% |
| Vantage Consulting Group Inc | 21,477,282 | $1,074,938,000 | 87.53% |
| Memorial Sloan Kettering Cancer Center | 3,565,887 | $178,473,000 | 75.56% |
| HARVARD MANAGEMENT CO INC | 14,690,780 | $735,274,000 | 39.88% |
| ROBERT WOOD JOHNSON FOUNDATION | 3,958,498 | $1,981,228,000 | 21.69% |
| Brown University | 381,759 | $19,107,000 | 13.82% |
| Overbrook Management Corp | 778,511 | $38,964,000 | 9.50% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 38,714,280 | $1,937,650,000 | 4.22% |
| Lagoda Investment Management, L.P. | 96,885 | $4,849,000 | 2.61% |
| HealthCor Management, L.P. | 1,339,530 | $67,043,000 | 2.58% |